17 clinical trials matched your search for Brain Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Brain Cancer Study of ONC201 in Adults With Recurrent H3 K27M-mutant Glioma Andrew Lassman, MD
Brain Cancer Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Brain Cancer Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) Andrew Lassman, MD
Brain Cancer A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Andrew Lassman, MD
Brain Cancer Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Fabio Iwamoto, MD
Brain Cancer Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary Central Nervous System (CNS) Lymphoma Aya Haggiagi, MD
Brain Cancer Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects Fabio Iwamoto, MD
Brain Cancer ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma Fabio Iwamoto, MD
Brain Cancer Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Brain Cancer Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Brain Cancer Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Brain Cancer Study of Vaccine for Cytomegalovirus (CMV) in Patients with Brain Tumor Andrew Lassman, MD
Brain Tumors Study of ONC201 in Adults With Recurrent H3 K27M-mutant Glioma Andrew Lassman, MD
Brain Tumors Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) Andrew Lassman, MD
Brain Tumors Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for Treatment of Newly Diagnosed Glioblastoma Fabio Iwamoto, MD
Cancer Study of MTX110 in Combination with Gadolinium in Children with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas) Luca Szalontay, MD
Brain Tumors Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD